Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 32, Issue 6, 2008, Pages 1031-1039

  Lieber, Charles S ^a   Weiss, David G ^a   Paronetto, Fiorenzo ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholic Liver Disease; Fibrosis Markers; Fibrosis Score

Indexed keywords

AMINO TERMINAL PROPEPTIDE OF TYPE III COLLAGEN; BIOLOGICAL MARKER; COLLAGEN TYPE 6; GELATINASE A; HYALURONIC ACID; LAMININ; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; STAGING;

ALGORITHMS; BIOLOGICAL MARKERS; BIOPSY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; LAMININ; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PEPTIDE FRAGMENTS; PHOSPHATIDYLCHOLINES; PLACEBOS; PROCOLLAGEN; ROC CURVE; SENSITIVITY AND SPECIFICITY; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

HEPATITIS C VIRUS;

EID: 44349132732     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00664.x     Document Type: Article

References (48)

1. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP (2005) Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 : 1867 1873.
2. Afdhal N (2005) Can serum markers be used to reliably detect liver fibrosis? Nat Clin Pract Gastroenterol Hepatol 2 : 132 133.
3. Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Amer J Gastro 99 : 1160 1174.
4. Albanis E, Friedman SL (2002) Noninvasive markers of hepatic fibrosis. Clinical Perspectives in Gastroenterology 182 : 182 187.
5. Arthur MJP (1995) Collagenases and liver fibrosis. J Hepatology 2 : 43 48.
6. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115 : 209 218.
7. Bissell DM (2004) Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology 127 : 1847 1849.
8. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P (2006) Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 13 : 659 670.
9. Burroughs A, Cholongitas E (2007) Non-invasive tests for liver fibrosis: encouraging or discouraging results? J. Hepatology 46 : 780 781.
10. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA (1994) A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20 : 349 355.
11. Forns X, Bataller R (2003) Can we identify liver fibrosis in HCV-infected patients without a liver biopsy? Curr Hepat Rep 2 : 145 151.
12. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 : 2247 2250.
13. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitions. J Clin Invest 102 : 538 549.
14. Laine F, Bendavid C, Moirand R, Tessier S, Perrin M, Guillygomarc'h A, Guyader D, Calon E, Renault A, Brissot P, Turlin B, Deugnier Y (2004) Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology 39 : 1639 1646.
15. Leroy V, Hilleret M-N, Sturm N, Trocme C, Renversez J-C, Faure P, Morel F, Zarski J-P (2007) Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatis C. J Hepatology 46 : 775 782.
16. Li JJ, Rosman AS, Leo MA, Nagai Y, Lieber CS (1994) Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19 : 1418 1423.
17. Lieber CS, Anand BS, Bini EJ, Leo MA, Lowe N, Murthy U, Paronetto F, Schiff E, Simon D (2005) Polyenylphosphatidylcholine (PPC) is beneficial for the treatment of hepatitis C patients. Hepatology 42 : 695A.
18. Lieber CS, Li JJ, DeCarli LM, Mak KM, Leo MA (1993) Dilinoleoylphosphatidylcholine stimulates collagen breakdown in lipocytes and protects against alcoholic cirrhosis, in Cells of the Hepatic Sinusoid, Vol. 4, Kuppfer Cell Foundation (Knook DL, Wisse E eds pp 239 241. Leiden, The Netherlands.
19. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the VA Cooperative Study 391 (2003a) I. VA Cooperative study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res 27 : 1757 1764.
20. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the VA Cooperative Study 391 (2003b) II. VA Cooperative study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27 : 1765 1772.
21. Lieber CS, Weiss D, Morgan T, Paronetto F (2006a) Aspartate Aminotransferase (AST) to platelet ratio index (APRI) in patients with alcoholic liver fibrosis. Amer J Gastro 101 : 1500 1508.
22. Lindqvist U (1997) Is serum hyaluronan a helpful tool in the management of patients with liver diseases? J Intern Med 242 : 67 71.
23. Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I (2006) Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 26 : 864 871.
24. Mardini H, Record C (2005) Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem 42 : 441 447.
25. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ (2000) Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Inferferon Study Group. J Gastroenterol Hepatol 15 : 945 951.
26. McHutchison J, Poynard T, Afdhal N, for the International Fibrosis Group Meeting Participants (2006) Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group. Clin Gastro Hepat 4 : 1214 1220.
27. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277 : 11069 11076.
28. Nakano M, Worner TM, Lieber CS (1982) Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 83 : 777 785.
29. Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T (2005) Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 3 : 167 174.
30. Niemelä O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H (1990) Markers of fibrosgenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 98 : 1612 1619.
31. Nouchi T, Worner TM, Sato S, Lieber CS (1987) Serum procollagen type III N-terminal peptides and lamini P1 peptide in alcoholic liver disease. Alcohol: Clin Exp Res 11 : 287 291.
32. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D, Cales P (1997) Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113 : 1609 1616.
33. Park G, Katelaris P, Jones DB, Ngu M, Le Couteur D (2005) Caution before embracing serum markers of liver fibrosis in clinical practice. Gastroenterology 128 : 1145 1146.
34. Patel K, Rockey DC (2006) Clinical utility of biomarkers of liver fibrosis. Gastroenterology and Hepatology 2 : 48 57.
35. Phillips MG, Preedy VR, Hughes RD (2003) Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Euro J Gastro Hepatol 15 : 941 944.
36. Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga MY, Gallois Y, Cales P (1998) Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. J Hep 28 : 439 446.
37. Ponomarenko Y, Leo MA, Kroll W, Lieber CS (2002) Effects of alcohol consumption on eight circulating markers of liver fibrosis. Alcohol Alcohol 37 : 252 255.
38. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 : 825 832.
39. Preaux A-M, D'Ortho M-P, Bralet M-P, Laperche Y, Mavier P (2002) Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology 36 : 615 622.
40. Rosenberg WM (2003) Rating fibrosis progression in chronic liver diseases. J Hepatology 38 : 357 360.
41. Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ, European Liver Fibrosis Group (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 : 1704 1713.
42. Sebastiani G, Alberti A (2006) Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 12 : 3682 3694.
43. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB 7 : 1434 1441.
44. Stickel F, Poeschl G, Schuppan D, Conradt C, Strenge-Hesse A, Fuchs FS, Hofmann WJ, Seitz HK (2003) Serum hylauronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 15 : 945 950.
45. Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP (2006) Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. J Viral Hepat 13 : 643 651.
46. Urashima S, Tsutsumi M, Nakase K, Takase S, Takada S (1993) Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol 28 : 77 84.
47. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS (2003) A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 : 518 526.
48. Worner TM, Lieber CS (1985) Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254 : 627 630.